MEDIA & PRESS

Press Releases & Company News

The latest announcements from Crassula Pharmaceuticals—science-driven breakthroughs, partnerships, and regulatory milestones. Assets and spokespeople are available for accredited media.

Latest releases news@crassulapharma.com press@crassulapharma.com
Browse Releases Download Media Kit
Relixib 120mg Comp
PRESS RELEASE

Crassula Launches Relixib, Etoricoxib 120mg Coated Tablet, in Honduras

Crassula Launches Relixib, Etoricoxib 120mg Coated Tablet, in Honduras Crassula Pharmaceuticals Launches Relixib, Etoricoxib 120mg, in Honduras Tegucigalpa, Honduras – Crassula Honduras, a leading pharmaceutical manufacturer renowned for its commitment to quality, is excited to announce the introduction of Relixib, an etoricoxib 120mg tablet, to the Honduran market. This new addition to Crassula’s portfolio reinforces the company’s dedication to providing

Read More »
March 24, 2024 No Comments
Welcome Team B G
PRESS RELEASE

Dr. Bhavana Gupta

Crassula Pharmaceuticals Welcomes Crassula is thrilled to announce the appointment of Dr. Bhavana Gupta as its new Chief Technical Officer (CTO). Dr. Gupta will be at the forefront of managing the technical operations of the company, including overseeing the research and development department. Her role will also encompass serving as a vital technical advisor, directly reporting to Mr. Roopesh Gupta,

Read More »
February 8, 2024 No Comments
Jan 25 Promoting Compassion and Understanding for World Cancer Day
NEWS

Cancer Remains A Threat In The Society

Cancer Remains A Threat In The Society Cancer is caused by disturbances in cell growth and behavior. In a healthy body, new white blood cells are regularly produced to replace old, dying blood cells. Blood cancer is caused by excessive production of white blood cells in the bone marrow. Why Is Cancer Still Growing?The biggest threats related to climate change

Read More »
February 4, 2024 No Comments
doctors
NEWS

Noncommunicable diseases (NCDs)

Noncommunicable diseases (NCDs) Tackling Noncommunicable Diseases: A Global Health Priority Noncommunicable diseases (NCDs), including cancer, heart disease, and diabetes, are among the most prevalent and rapidly escalating health issues facing society today. These conditions, characterized by their non-transmissible nature, contribute to approximately three-quarters of all global deaths, highlighting a significant public health challenge. Alarmingly, about 77% of NCD-related fatalities occur

Read More »
February 2, 2024 1 Comment
Gasflum - Esomeprazol
DIABETIC

Crassula Pharma Lauches In Honduras

Crassula Pharmaceuticals Launches in Honduras Crassula Pharmaceuticals Launches Gasflum, Esomeprazole 40mg Coated Tablet, in Honduras Tegucigalpa, Honduras – Crassula Honduras, a premier pharmaceutical manufacturer, proudly announces the launch of Gasflum, an esomeprazole 40mg coated tablet, enhancing its portfolio of high-quality healthcare solutions in Honduras. Designed for effective management of acid reflux and related conditions, Gasflum offers a significant advancement in

Read More »
February 1, 2024 2 Comments